Story Navigation
-
Access to HealthcareAccess to HealthcareFuture of HealthcareGlobal Health PartnershipsNovartis Social BusinessSustainable Development
Making healthcare sustainable in the developing world
Today, many companies are trying to solve global health challenges through philanthropy. However, it has become clear that philanthropy alone is no longer enough to make a lasting impact.
Access to Healthcare -
DiscoveryChildren's HealthGene SequencingInnovationNeurodegenerative DiseaseRare Diseases
Tackling a rare disease: Working toward a treatment for SMA
Most people have never heard of spinal muscular atrophy (SMA), a rare genetic disease that affects approximately 1 in 6,000 babies born worldwide each year. Innovative research may produce treatments for patients suffering from SMA and other rare diseases.
Discovery -
From Our LabsBiomedical ResearchDigitalEmerging TechnologyFuture of HealthcareInnovationNovartis Institutes for BioMedical Research
Surfing the wave of big data analytics
The cause of a rare, inherited, often fatal kidney disease in many patients remained elusive for years, despite multiple attempts to solve the mystery. Then in 2012, a team of researchers cracked some of the unsolved cases in just six weeks.
From Our Labs -
DiscoveryNovartis Institutes for BioMedical Research
Physician-Scientist Donald Ganem takes the reins in Infectious Disease
Discovery
Pagination
- ‹ Previous page
- 1
- …
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- › Next page